0001209191-21-003472.txt : 20210113
0001209191-21-003472.hdr.sgml : 20210113
20210113190709
ACCESSION NUMBER: 0001209191-21-003472
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210112
FILED AS OF DATE: 20210113
DATE AS OF CHANGE: 20210113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hove Anders D
CENTRAL INDEX KEY: 0001365618
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22873
FILM NUMBER: 21527125
MAIL ADDRESS:
STREET 1: 30 ROCKEFELLER PLAZA, SUITE 5508
CITY: NEW YORK
STATE: NY
ZIP: 10112
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARCA biopharma, Inc.
CENTRAL INDEX KEY: 0000907654
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 363855489
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11080 CIRCLEPOINT ROAD
STREET 2: SUITE 140
CITY: WESTMINSTER
STATE: CO
ZIP: 80020
BUSINESS PHONE: 720-940-2200
MAIL ADDRESS:
STREET 1: 11080 CIRCLEPOINT ROAD
STREET 2: SUITE 140
CITY: WESTMINSTER
STATE: CO
ZIP: 80020
FORMER COMPANY:
FORMER CONFORMED NAME: NUVELO INC
DATE OF NAME CHANGE: 20030203
FORMER COMPANY:
FORMER CONFORMED NAME: HYSEQ INC
DATE OF NAME CHANGE: 19970610
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-12
0
0000907654
ARCA biopharma, Inc.
ABIO
0001365618
Hove Anders D
10170 CHURCH RANCH WAY
SUITE 100
WESTMINSTER
CO
80021
1
0
0
0
Stock Option (right to buy)
4.31
2021-01-12
4
A
0
12000
0.00
A
2031-01-12
Common Stock
12000
12000
D
Grant to the Reporting Person of a stock option under the 2020 Equity Incentive Plan, vesting in 36 equal monthly installments beginning as of December 21, 2020. If the Reporting Person's service as a director of the Issuer terminates in connection with or at any time following a change in control (for whatever reason), then any unexpired options that remain unvested shall become fully vested.
/s/ Brian L. Selby, Attorney-in-Fact
2021-01-13